Episode 2: The Changing Landscape of Cardiac Imaging

Update: 2024-12-13

Description

Radionuclide perfusion imaging remains the dominant force in coronary artery disease assessment, with SPECT leading the charge and PET on a steady rise. In this episode of JNC CardioConnect, Journal of Nuclear Cardiology (JNC) Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, speaks with physicians at Houston Methodist Hospital to discuss their recent article and break down the latest Medicare data, highlighting usage trends in cardiac imaging, underutilized opportunities with PET/CT and myocardial blood flow, and what it all means for the future of cardiac imaging.

Comments

In Channel

In a Heartbeat: Episode 9

2025-08-2219:26

Episode 8: When normal SPECT isn’t reassuring—Rethinking risk in exercise SPECT

2025-08-1519:43

Episode 7: Using Hybrid SPECT/CT Imaging to Guide Patient Management

2025-07-0219:16

Episode 6: Flow Reserve and the Hidden Timeline of Vascular Health

2025-05-0615:09

Episode 5: JNC Compendium: F-18 Flurpiridaz PET Myocardial Perfusion Imaging with Panithaya Chareonthaitawee, MD, Krishna Patel, MD, MS, FASNC, and Rob S.B. Beanlands, MD, MASNC

2025-03-2724:25

Current practices and trends in amyloidosis imaging with bone-avid tracer cardiac scintigraphy with Jamieson M. Bourque, MD, MHS, FASNC, Sarah AM. Cuddy, MD, FASNC, and Nishant Shah, MD, MPH, FASNC

2025-02-2017:35

Episode 3: Effect of Imaging Timing on the Assessment of Treatment Response in Cardiac Sarcoidosis with Chaitanya Rojulpote, MD, Paco E. Bravo, MD, and Sanjay Divakaran, MD, FASNC

2025-01-2813:42

Episode 2: The Changing Landscape of Cardiac Imaging

2024-12-1312:22

Episode 1: Role of Quantitative Radionuclide Imaging in Cardiac Amyloidosis

2024-11-1912:34